The US Food and Drug Administration has approved azelastine HCl 0.15% nasal spray for the treatment of seasonal and perennial allergic rhinitis in patients 12 years and older.

CyDex Pharmaceuticals announced the presentation of Phase 2 clinical trial results of its Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).

A new study illustrated that early azelastine nasal spray therapy might lower the SARS-CoV-2 load among virus-infected patients.

Co announced Sunday that the prescription antihistamine Astelin (azelastine HCl) Nasal Spray relieved the major symptoms of pollen allergy, including sneezing, runny nose and congestion, within 15 ...

The FDA has approved Astepro (azelastine nasal spray, from Meda), a reformulation of Astelin, for the treatment of seasonal allergic rhinitis.

PHILADELPHIA -- Olopatadine in nasal spray form may provide an option to azelastine (Astelin) for seasonal allergic rhinitis, a researcher said here.

How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?

Azelastine nasal spray was previously approved for twice-daily use at a dose of 2 sprays per nostril in this population, and at a dose of 1 spray per nostril in patients aged 5 to 11 years with ...

The spray, Astepro, is a reformulation of Astelin. The company said it is an improvement over Astelin that is easier for patients to tolerate. The active pharmaceutical ingredient in both drugs is ...

Hay fever sufferers may get better relief from a nasal antihistamine than from an oral antihistamine, a clinical trial shows. Astelin is a twice-a-day nasal spray. Zyrtec is a once-a-day pill ...